{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:13:59Z","timestamp":1793142839624,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113025","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:04:20Z","timestamp":1725627860000},"page":"113025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders"],"prefix":"10.1016","volume":"142","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-3310","authenticated-orcid":false,"given":"Fujun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2024.113025_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113025_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113025_b0015","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113025_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113025_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60904-8","article-title":"Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation","volume":"10","author":"Nagasaki","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2024.113025_b0030","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/nu14071482","article-title":"The Role of Palmitoleic Acid in Regulating Hepatic Gluconeogenesis through SIRT3 in Obese Mice","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.113025_b0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.foodres.2014.01.015","article-title":"Monitoring the quality of \u03b3-irradiated macadamia nuts based on lipid profile analysis and Chemometrics. Traceability models of irradiated samples","volume":"60","author":"Sinanoglou","year":"2014","journal-title":"Food Res. Int."},{"issue":"8","key":"10.1016\/j.intimp.2024.113025_b0040","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/jcp.25715","article-title":"Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPAR\u03b1-Dependent AMPK Activation","volume":"232","author":"Oliveira","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113025_b0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7326\/0003-4819-153-12-201012210-00005","article-title":"Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adultd","volume":"153","author":"Mozaffarian","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2024.113025_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.appet.2013.01.009","article-title":"Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats","volume":"65","author":"Zhihong","year":"2013","journal-title":"Appetite"},{"issue":"12","key":"10.1016\/j.intimp.2024.113025_b0055","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1271\/bbb.110509","article-title":"Regulation of Lipid Metabolism by Palmitoleate and Eicosapentaenoic Acid (EPA) in Mice Fed a High-Fat Diet","volume":"75","author":"Shiba","year":"2011","journal-title":"Biosci. Biotech. Bioch."},{"issue":"4","key":"10.1016\/j.intimp.2024.113025_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.intimp.2024.113025_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.113025_b0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.intimp.2024.113025_b0075","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.lpm.2019.09.051","article-title":"Pathophysiology of metabolic hepatic steatosis","volume":"48","author":"Anty","year":"2019","journal-title":"Presse Med."},{"issue":"27","key":"10.1016\/j.intimp.2024.113025_b0080","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113025_b0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113025_b0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.intimp.2024.113025_b0095","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"7784","key":"10.1016\/j.intimp.2024.113025_b0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113025_b0105","doi-asserted-by":"crossref","first-page":"101635","DOI":"10.1016\/j.redox.2020.101635","article-title":"Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy","volume":"36","author":"Gao","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113025_b0110","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2211501","article-title":"Dietary palmitoleic acid reprograms gut microbiota and improves biological therapy against colitis","volume":"15","author":"Chen","year":"2023","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.intimp.2024.113025_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1079\/BJN2002521","article-title":"Dietary myristic acid modifies the HDL-cholesterol concentration and liver scavenger receptor BI expression in the hamster","volume":"87","author":"Carole Loison","year":"2002","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.intimp.2024.113025_b0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.intimp.2024.113025_b0125","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.labinv.2023.100129","article-title":"Comparison of Animal Models for the Study of Nonalcoholic Fatty Liver Disease","volume":"103","author":"Zheng","year":"2023","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2024.113025_b0130","doi-asserted-by":"crossref","unstructured":"Hao Wang,Chun-Lang Shan,Bin Gao,Jin-Long Xiao,Jue Shen,Jingang Zhao,Dongmei Han,Bin-Xun Chen,Shuai Wang,Gen Liu,Ai-Guo Xin,L. Y. Lv,Xiao Peng, Hong Gao (2023). Yersiniabactin-Producing E. coli Induces the Pyroptosis of Intestinal Epithelial Cells via the NLRP3 Pathway and Promotes Gut Inflammation. International Journal of Molecular Sciences, 24 (14), 11451-11451. Doi: 10.3390\/ijms241411451.","DOI":"10.3390\/ijms241411451"},{"issue":"3","key":"10.1016\/j.intimp.2024.113025_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/toxins15030171","article-title":"Hemolysin Co-Regulatory Protein 1 Enhances the Virulence of Clinically Isolated Escherichia coli in KM Mice by Increasing Inflammation and Inducing Pyroptosis","volume":"15","author":"Wang","year":"2023","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.intimp.2024.113025_b0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Guangchuang","year":"2012","journal-title":"OMICS"},{"issue":"W1","key":"10.1016\/j.intimp.2024.113025_b0145","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Yang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113025_b0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10534-014-9807-7","article-title":"The role of NOS-mediated ROS accumulation in an early phase Cu-induced acute cytotoxicity in MCF-7 cells","volume":"28","author":"Zhong","year":"2014","journal-title":"Biometals"},{"issue":"3","key":"10.1016\/j.intimp.2024.113025_b0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113025_b0160","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.intimp.2024.113025_b0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1194\/jlr.M079145","article-title":"Occurrence and biological activity of palmitoleic acid isomers in phagocytic cells","volume":"59","author":"Astudillo","year":"2018","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113025_b0170","article-title":"Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4\u03b3, HNF4\u03b1 and IL6 in patients with ulcerative colitis","volume":"63","author":"Nallely Bueno-Hern\u00e1ndez","year":"2017","journal-title":"Minerva gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113025_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2014.06.010","article-title":"Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance","volume":"393","author":"Talbot","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113025_b0180","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","article-title":"Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism","volume":"134","author":"Cao","year":"2008","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2024.113025_b0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S2213-8587(22)00167-X","article-title":"How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?","volume":"10","author":"Byrne","year":"2022","journal-title":"The Lancet Diabetes Endocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113025_b0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2468-1253(19)30429-7","article-title":"Headway and hurdles in non-alcoholic fatty liver disease","volume":"5","author":"The Lancet Gastroenterology Hepatology","year":"2020","journal-title":"The Lancet Gastroenterology Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113025_b0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.113025_b0200","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3390\/nu12113472","article-title":"Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"12","author":"Carneros","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.intimp.2024.113025_b0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.intimp.2024.113025_b0210","doi-asserted-by":"crossref","unstructured":"Camila Oliveira de Souza,Andreza Corr\u00eaa Teixeira,Luana Amorim Biondo,Loreana Sanches Silveira,Cristiane Naffah de Souza Breda,T\u00e1rcio Teodoro Braga,Niels Olsen Saraiva C\u00e2mara,Thiago Belchior,William T. Festuccia,Tiego Aparecido Diniz,Gl\u00e1ucio Monteiro Ferreira,M\u00e1rio Hiroyuki Hirata,Adriano B. Chaves\u2010Filho,Marcos Yukio Yoshinaga,Sayuri Miyamoto,Philip C. Calder,J. Sethi, Jos\u00e9 Cesar Rosa Neto (2020). Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-\u03b3-independent M2a polarization of myeloid cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1865 (10), 158776-158776. Doi: 10.1016\/j.bbalip.2020.158776.","DOI":"10.1016\/j.bbalip.2020.158776"},{"issue":"12","key":"10.1016\/j.intimp.2024.113025_b0215","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202001025","article-title":"Palmitoleic Acid Protects against Hypertension by Inhibiting NF-\u03baB-Mediated Inflammation","volume":"65","author":"Tang","year":"2021","journal-title":"Molecular Nutrition Food Research"},{"key":"10.1016\/j.intimp.2024.113025_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.537061","article-title":"Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice","volume":"11","author":"Cruz","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2024.113025_b0225","doi-asserted-by":"crossref","first-page":"174351","DOI":"10.1016\/j.ejphar.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4","volume":"908","author":"Zhu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113025_b0230","article-title":"Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia\/reperfusion","volume":"7","author":"Qing-Zhang Tuo","year":"2022","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:52:53Z","timestamp":1727995973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924015467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S1567576924015467"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113025","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113025"}}